Taiwan - Draft Regulation for the Use Restriction and Labeling Requirement of 2′-Fucosyllactose Produced by Genetically Modified Escherichia Coli Strain K-12 DH1 MDO MAP1001d as a Food Ingredient
Business description
Taiwan Food and Drug Administration is proposing to regulate the use restriction and labeling requirement of 2'-fucosyllactose produced by genetically modified Escherichia coli strain K-12 DH1 MDO MAP1001d for food purposes.
Proposed date of adoption: To be determined
Proposed date of entry into force: To be determined
Final date for comments: 02/19/2021
Source: G/TBT/N/TPKM/447
Countries:
Taiwan
Technical aspects:
Safety
Business fields:
P.01 Softlines
Regions:
Asia
Disclaimer
The content of our website has been compiled with meticulous care and to the best of our knowledge. However, we cannot assume liability on the page content to be up-to-date, complete or accurate.